US Stock MarketDetailed Quotes

SNDX Syndax Pharmaceuticals

Watchlist
  • 18.860
  • -0.060-0.32%
Close Oct 31 16:00 ET
  • 18.999
  • +0.139+0.73%
Post 16:08 ET
1.60BMarket Cap-5547P/E (TTM)

Syndax Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Syndax Pharmaceuticals Q3 2024 Estimates Date

Currency：USDNov 5, 2024

Estimate YoY
Revenue
8.40M
--
EPS
-1.03
-40.72%
Analyst Rating
Strong Buy

Oct 31, 2024

Syndax Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 12 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 27.866M--
Nov 5, 20242024/Q3-- / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Feb 27, 20242023/Q40.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 27.866M--
Nov 5, 20242024/Q3-- / 8.399M--
Aug 1, 20242024/Q23.500M / 0.000--
May 8, 20242024/Q10.000 / 0.000--
Feb 27, 20242023/Q40.000 / 0.000--

Unlock Free Earnings Estimates

Syndax Pharmaceuticals Earnings Reports

  • Syndax Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:06 ET

  • Syndax Pharmaceuticals | 10-Q: Q1 2024 Earnings Report

    May 8 07:08 ET

  • Syndax Pharmaceuticals | 10-K: FY2023 Annual Report

    Feb 27 22:50 ET

  • Syndax Pharmaceuticals | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:05 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 31, 2024

    Strong Buy

    • Buy

      91.67%

    • Hold

      8.33%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data